Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies
Jianheng Liu,Liang Zhou,Jiao Xu,Zhengsheng Liu,Keya Mao,Peifu Tang,Kezheng Mao,Xiumei Wang,Wenguang Guo
DOI: https://doi.org/10.1166/jbt.2015.1308
2015-01-01
Journal of Biomaterials and Tissue Engineering
Abstract:The objective of this study was to investigate the feasibility of calcium sulfate hemihydrate/mineralized collagen (CSH/nHAC) as a carrier for sustained release of BMP-2 derived peptide and in vivo bone formation capacity. A peptide was fabricated according to sequence of peptide in BMP-2 active core region by the FMOC/tBu solid-phase peptide synthesis. CSH/nHAC was prepared and observed with scanning electron microscope. BMP-2 derived peptide was introduced into CSH/nHAC. For observing the release kinetics of BMP-2 derived peptide, the released content from CSH/nHAC was detected using high performance liquid chromatography at different time points. CSH/nHAC loaded with BMP-2 derived peptide as Group A and CSH/nHAC without BMP-2 derived peptide as Group B were respectively implanted into a critical size defect model in the femoral condyle of rabbit. At the same time, we set up the control group as group C. Up to 4th, 8th and 12th week after implantation, the rabbits were killed in batch, and the samples were harvested and detected by X-rays, Micro CT, and histological observation. The released character of BMP-2 derived peptide was that an initial burst release (32.9%) was observed in the first day, followed by a sustained release and reached 100% by day 25. The results of X-rays, Micro CT and histological observation indicated that more new bone was formed in Group A, and the difference was marked at each stage. Through histological quantitative analysis, a significant difference in the new bone formation was found in these three groups. Consequently, we conclude that CSH/nHAC can be served as a carrier for sustained release of BMP-2 derived peptide and CSH/nHAC loaded with BMP-2 derived peptide has a great potential in bone tissue engineering.